Recombinant urokinase is safe and effective in restoring patency to occluded central venous access devices: A multiple-center, international trial

Critical Care Medicine

Volumn 32, Issue 10, 2004, Pages 1990-1996

  Svoboda, Petr ^a   Barton, R Philip ^b   Barbarash, Olga L ^c   Butylin, Alexey A ^c   Jacobs, Brian R ^d   Lata, Jan ^e   Haire, William D ^f   Jaff, Michael R ^g   Firszt, Carolyn M ^h   Mouginis, Tamyra L ^h   Schuerr, Debra M ^h   Schulz, Gregory A ^h   Schwartz, Lewis B ^h   El Shahawy, Mohamed A ⁱ  

^a MASARYK UNIVERSITY   (Czech Republic)

^b Children's Hospital at Saint Francis   (United States)

^c Clinic of Therapy   (Russian Federation)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^f UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^g LENOX HILL HOSPITAL   (United States)

^h ABBOTT LABORATORIES   (United States)

ⁱ UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Central venous access device occlusion; Intracatheter thrombolysis; Multiple center study; Open label study; Recombinant urokinase

Indexed keywords

ALTEPLASE; ANTICOAGULANT AGENT; UROKINASE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; CENTRAL VENOUS CATHETER; CHILD; CLINICAL PROTOCOL; CLINICAL TRIAL; COMORBIDITY; DEATH; DRUG EFFICACY; DRUG SAFETY; ESOPHAGUS HEMORRHAGE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; INFANT; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEWBORN; OCCLUSION; OPEN STUDY; PRIORITY JOURNAL; SEPSIS; TREATMENT INDICATION; VASCULAR PATENCY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; EQUIPMENT FAILURE; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATORS; THROMBOLYTIC THERAPY; THROMBOSIS; TREATMENT OUTCOME; URINARY PLASMINOGEN ACTIVATOR;

EID: 5644239518     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000142706.01717.EB     Document Type: Article

References (17)

1. Maki DG, Stolz SM, Wheeler S, et al: Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. Ann Intern Med 1997; 127:257-266
2. O'Grady NP, Alexander M, Dellinger EP, et al: Guidelines for the prevention of intravascular catheter-related infections. MMWR Recomm Rep 2002; 51:1-26
3. Beathard G: Catheter thrombosis. Semin Dial 2001; 14:441-445
4. Kenney BD, David M, Bensoussan AL: Anti-coagulation without catheter removal in children with catheter-related central vein thrombosis. J Pediatr Surg 1996; 31: 816-818
5. Haire WD, Atkinson JB, Stephens LC, et al: Urokinase versus recombinant tissue plasminogen activator in thrombosed central venous catheters: A double-blind randomized trial. Thromb Haemost 1994; 72:543-547
6. Deitcher SR, Fesen MR, Kiproff PM, et al: Safety and efficacy of alteplase for restoring function in occluded central venous catheters: Results of the Cardiovascular Thrombolytic to Open Occluded Lines Trial. J Clin Oncol 2002; 20:317-324
7. Ponec D, Irwin D, Haire WD, et al: Recombinant tissue plasminogen activator (Alteplase) for restoration of flow in occluded central venous access devices: A double-blind placebo-controlled trial. The Cardiovascular Thrombolytic to Open Occluded Lines (COOL) efficacy trial. J Vasc Interv Radiol 2001; 12:951-955
8. Jacobs BR, Haygood M, Hingl J: Recombinant tissue plasminogen activator in the treatment of central venous catheter occlusion in children. J Pediatr 2001; 139:593-596
9. Hurtubise MR, Bottino JC, Lawson M, et al: Restoring patency of occluded central venous catheters. Arch Surg 1980; 115:212-213
10. Glynn MF, Langer B, Jeejeebhoy KN: Therapy for thrombotic occlusion of long-term intravenous alimentation catheters. JPEN J Parenter Enteral Nutr 1980; 4:387-390
11. Lawson M, Bottino JC, Hurtubise MR, et al: The use of urokinase to restore the patency of occluded central venous catheters. Am J Intraven Ther Clin Nutr 1982; 9:29-32
12. Wachs T: Urokinase administration in pediatric patients with occluded central venous catheters. J Intraven Nurs 1990; 13:100-102
13. Lewis CA, Allen TE, Burke DR, et al: Quality improvement guidelines for central venous access. J Vase Interv Radiol 2003; 14: S231-S235
14. McGee DC, Gould MK: Preventing complications of central venous catheterization. N Engl J Med 2003; 348:1123-1133
15. Graafsma YP, Prins MH, Lensing WA, et al: Bleeding classification in clinical trials: Observer variability and clinical relevance. Thromb Haemost 1997; 78:1189-1192
16. Wever MLG, Liem KD, Geven WB, et al: Urokinase therapy in neonates with catheter related central venous thrombosis. Thromb Haemost 1995; 73:180-185
17. Ouriel K, Veith FJ, Sasahara AA: A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. N Engl J Med 1998; 338:1105-1111